Overview

Neoadjuvant Treatment of Colon Cancer

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study will investigate - the effect of preoperative combination chemotherapy in patients with locally advanced colon cancer with mutation in the KRAS, BRAF or PIK3CA gene - the effect of preoperative combination chemotherapy in combination with biological treatment in patients without mutation in the KRAS, BRAF or PIK3CA gene.

Phase:

Phase 2

Details

Lead Sponsor:

Vejle Hospital

Collaborator:

Herlev Hospital

Treatments:

Capecitabine
Oxaliplatin
Panitumumab